Vivesto AB is a research and development company that develops new treatment options for patients suffering from difficult-to-treat cancer... Show more
Industry PharmaceuticalsOther
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DPG | 11.67 | 0.05 | +0.43% |
Duff & Phelps Utility and Infrastructure Fund | |||
RSF | 15.14 | -0.02 | -0.16% |
RiverNorth Capital and Income Fund | |||
PVAL | 37.30 | -0.60 | -1.58% |
Putnam Focused Large Cap Value ETF | |||
YJUN | 22.90 | -0.41 | -1.77% |
FT Vest Intl Eq Mod Bf ETF June | |||
FBZ | 9.60 | -0.26 | -2.64% |
First Trust Brazil AlphaDEX® ETF |
A.I.dvisor tells us that OASMY and MVMDF have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OASMY and MVMDF's prices will move in lockstep.
Ticker / NAME | Correlation To OASMY | 1D Price Change % | ||
---|---|---|---|---|
OASMY | 100% | N/A | ||
MVMDF - OASMY | 9% Poorly correlated | -18.64% | ||
MKGAF - OASMY | 4% Poorly correlated | -1.14% | ||
NXSCF - OASMY | 4% Poorly correlated | N/A | ||
PCLOF - OASMY | 2% Poorly correlated | -12.29% | ||
NDVAF - OASMY | 2% Poorly correlated | N/A | ||
More |
Ticker / NAME | Correlation To OASMY | 1D Price Change % |
---|---|---|
OASMY | 100% | N/A |
Pharmaceuticals category (306 stocks) | -2% Poorly correlated | -0.52% |
Pharmaceuticals: Other category (216 stocks) | -7% Poorly correlated | -0.12% |